Indoco pares gains, end down 1%

The stock ended at Rs 166, down 1%. The counter witnessed comparatively thin volumes of 565 shares as against its two-week daily traded average of 1,096 shares.
__________________________________________________________
(Updated at 1333 hrs)

Indoco Remedies is up over 1% at Rs 169, on the back of the news that the company had received approval from the European Union for its injectable drug manufacturing site in Goa.

The stock has touched a high of Rs 171 and a low of Rs 165. The counter has witnessed sparse trades of around 469-odd shares so far on the BSE.

Indoco Remedies' facility in Goa for injectables has been certified as Good Manufacturing Practices (GMP) compliant in accordance with EU-GMP principles and guidelines as issued in a release.